Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep480 | Pituitary and Neuroendocrinology | ECE2021

What should be the optimal testosterone level to improve the symptoms of hypogonadism in male macroprolactinomas?

Caklili Ozge Telci , Ayşe Merve Çelik , Istemihan Zulal , Selcukbiricik Ozlem Soyluk , Yarman Sema

ObjectivesMale prolactinoma patients mostly have hypogonadotropic symptoms. While treatment with dopamine agonists (DAs; such as bromocriptine or cabergoline) leads to recovery of sexual glands, it can lead to impulsive control disorders as an undesirable side effect. The aim of this retrospective study is to determine the level of testosterone that eliminates symptoms, provides fertility and does not cause this undesirable side effect regardless of prol...